Finding the best dose of growth hormone for short children
Treatments studied
Part of Bones, joints & muscles, Genetic & congenital, Hormones & metabolism clinical trials.
This study tests different doses of a long-acting growth hormone (PEG-rhGH) to find the best amount for helping children with short stature grow more. It includes kids who are not yet in puberty or who are in the early to middle stages of puberty.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child has short stature or a predicted adult height well below normal.
- Your child is either pre-pubertal (no signs of puberty) or in early to mid-puberty (Tanner stages I–IV).
- You and your child are willing to follow the study schedule and get regular check-ups.
- Your child has no severe health conditions like cancer, serious organ disease, or known allergies to the study drug.
- Your child has not been in another clinical trial or taken any experimental drugs in the past 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if growth hormone can safely help children who are shorter than average for their age and gender. It is for children with certain conditions that cause short stature.
This trial tests a weekly growth hormone injection called PEG-rhGH to see if it helps short children born small for gestational age grow taller. It may be an option if your child has never taken growth hormone before and meets the height and age requirements.
This trial tests if a long-acting growth hormone (PEGylated GH) helps children with various causes of short stature grow taller. It may be an option if your child has a condition like growth hormone deficiency, Turner syndrome, or idiopathic short stature.
This study tests whether an investigational drug can help children with idiopathic short stature (short height with no known cause) grow taller. It may be an option for children who are very short for their age and have not responded well to standard growth hormone therapy.
This study tests an experimental growth hormone (Inpegsomatropin) to help children born small for gestational age who remain short. If your child meets the specific height, age, and puberty criteria, they may qualify.
This study tests a new growth hormone injection (Inpegsomatropin) to help children with idiopathic short stature (short stature with no known cause) grow taller. It may be an option if your child is very short compared to peers and has not started puberty.
Hear when a new Short Stature trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.